Cart 0 $0.00
IRE favicon


Resource ID: #19320
Subject: Pharmaceuticals
Source: New York Times
Date: 2000-07-23


The New York Times examined court records and other public documents in Washington and other states and interviewed regulators and drug company executives with a particular focus on Hytrin. The review showed how efforts to extend a profitable drub's monopoly, as much as the pursuit of scientific discoveries, drive decisions in one of the world's most lucrative, and secretive, industries.

This file is not available for digital download. IRE members may place an order by emailing

109 Lee Hills Hall, Missouri School of Journalism   |   221 S. Eighth St., Columbia, MO 65201   |   573-882-2042   |   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
My cart
Your cart is empty.

Looks like you haven't made a choice yet.